Medplus Health Services Ltd. · NSE:MEDPLUS
Medplus Health Services — Q1 FY2026 Earnings Presentation
26 slides from Medplus Health Services's earnings presentation, Aug 2, 2025
Slide 1: Exchange filing cover letter for earnings call presentation
MedPlus Health Services Limited August 02, 2025 The Listing Department The Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Mumbai 400 001 Bandra (East), Mumbai – 400 051 BSE Scrip Code: 543427
Slide 2: MedPlus Health Services Limited Q1 FY2026 Investor Presentation
MEDPLUS HEALTH SERVICES LIMITED Q1 FY2026 INVESTOR PRESENTATION August 2025
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by MedPlus Health Services Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for
Slide 4: The MedPlus Story
The MedPlus Story Overview Marked presence of 19 years with network of 4,800+ Stores Spread across 13 states and 1 union territory Cluster based expansion strategy: ‘Continue 2nd Largest Pharma Retailer in the country deeper penetration vs. with pioneer in omni channel Wider reach’ Well curated SKU’
Slide 5: Q1 FY2026 Highlights (1/2)
Results Update Q1 FY2026 Highlights (1/2) ₹ 15,426m Revenue ₹ 4,029m Gross Margin • ₹ 538m increase over Q1FY25 3.6% • 26.1% GM%, decreased by 40 bps yoy qoq and increased by 400 bps yoy • ₹ 330m increase over Q4FY25 2.2% qoq • 5.7% increase in private label over Q1FY25 101 Store Net Additions Store
Slide 6: Q1 FY2026 Highlights (2/2)
Results Update Q1 FY2026 Highlights (2/2) Revenue, ₹m Gross Margin Operating EBITDA EBITDA, ₹m 26.6% 26.1% 5.3% 1,522 15,762 25.0% 5.1% 1,450 1,457 15,614 15,426 23.7% 4.7% 22.1% 4.7% 1,360 Consolidated 14,888 15,096 1,025 2.9% 799 803 739 728 435 15,460 15,325 15,106 25.5% 25.0% 5.1% 5.2% 1,488 24.
Slide 7: Cluster Based Network Enables Profitable Omni-Channel Service
Cluster Based Network Enables Profitable Omni-Channel Service Overview Stores As On June-25 Strong Cluster Based Network Strong network of 4,813 stores across Metros, Tier-One, Tier-Two and beyond. 4,813 stores 2- hour delivery Ability to service 100% market – acute + chronic Online only players can
Slide 8: Scale Allows A Large Private Label Basket: 1350+ SKUs
Scale Allows A Large Private Label Basket: 1350+ SKUs Overview Pharma Over 820 products covering Chronic, Acute, OTC & Other Pharmaceutical products Non-Pharma Over 540 products covering, packaged food, baked goods, dry goods, cleaning products, cosmetics and toiletries Q1FY26 6
Slide 9: Poised for Growth
Poised for Growth Overview Key Pillars Of Growth MedPlus has an established base of operations in 13 states and 1 union territory. Therefore, we will: Growth in existing clusters and • Further grow in cities where we have market leadership. Metro and Tier - One followed A develop new clusters by Tie
Slide 10: Stores Added In Last Months
Results Update 369 Stores Added In Last 12 Months As On Jun-24 As On Mar-25 As On Jun-25 Presence 4,444 4,712 4,813 We are present in stores stores stores 13 states and 1 union territory. 1 1 The key urban 1 1 centers are: Bangalore, 14 596 19 665 26 674 Chennai, 26 39 42 Hyderabad, 553 160 559 174
Slide 11: Stores Added In Last Quarter
Results Update 101 Stores Added In Last Quarter Q1 FY26 Openings Q1 FY26 Closures Q1 FY26 Closure Reasons 8.3 We opened 124 4.5 124 23 3 stores in Q1FY26. stores stores There were 23 8 closures 2.6 4 7 10 1 3 1 15 2 8 3.6 31 8 20 3 13 4 Relocation Franchisee withdrawn 21 5 3 Conversion to Franchisee
Slide 12: Store Network: 21% Less Than 1 Year Old
Results Update Store Network: 21% Less Than 2 Years Old Pharmacy: Count Pharmacy: Age Structure of Stores1 Stores 4.444 4,552 4,612 4,712 4,813 8% 9% 13% 12% 11% 100 101 Openings 108 60 37 14% 12% 4,500 Maintaining 16% 18% steady store 4,000 23% openings 3,500 3,000 2,500 4,552 4,612 4,712 4,407 4,4
Slide 13: Profitable Older Stores: 12+ Months
Results Update Profitable Older Stores: 12+ Months Store Level Revenue Growth1 Store Level EBITDA Margin Store Level Operating ROCE2,3 61.7% 59.2% 59.8% 9.8% 11.5% 58.1% 11.0% 10.9% 10.2% 6.8% 9.3% 46.1% 4.4% -0.2% -0.9% Q1FY25 Q2FY25 Q3FY25 Q4FY25 Q1FY26 Q1FY25 Q2FY25 Q3FY25 Q4FY25 Q1FY26 Q1FY25 Q2
Slide 14: Revenue Mix: Increasing Share Of Private Label
Results Update Revenue Mix: Increasing Share Of Private Label Revenue Mix: By Product Category Revenue Mix3: By Location of Stores 3.5% 3.7% 3.1% 3.4% 3.9% Product mix 6.7% 12% 12% 13% 13% 13% 7.9% 8.3% 9.7% 8.7% Trend of 9.1% increasing share 10.5% 11.3% 13.6% 12.8% from Private 11.2% 23% 23% 24% 2
Slide 15: Omni-channel: Profitable With Negligible Acquisition Costs
Results Update Omni-channel: Profitable With Negligible Acquisition Costs Channel Revenue Channel Delivery Pincodes1 and Delivery Hubs 880 8.0% 100% 875 873 Hubs 620 630 636 598 637 870 Home Delivery Omni-Channel 870 7.0% Our online 863 80% presence grows 860 6.0% 2,867 2,858 2,935 on the back of 2,
Slide 16: Income Statement
Results Update Income Statement Snapshot of Income Statement, ₹m Q1FY26 vs. Q1FY26 vs. Q1FY25 Q4FY25 Q1FY26 Q1FY25 (yoy) Q4FY25(qoq) Revenue 14,888.3 15,096.1 15,426.3 3.6% 2.2% Gross Margin 3,292.6 4,009.7 4,029.0 22.4% 0.5% Gross Margin 22.1% 26.6% 26.1% Expenses 2,858.0 3,206.4 3,300.9 15.5% 2.9%
Slide 17: Income Statement: Business Segments
Results Update Income Statement: Business Segments Snapshot of Income Statement, ₹m Q4FY25 Q1FY26 Pharmacy Pharmacy Diagnostic Others Total Diagnostic Others Total Retail Retail Revenue 14,797.6 280.8 17.7 15,096.1 15,106.4 302.9 17.0 15,426.3 COGS and Expenses 14,028.5 246.5 17.9 14,292.8 14,416.3
Slide 18: Income Statement: Ind AS Adjustments
Results Update Income Statement: Ind AS Adjustments Snapshot of Income Statement: Ind AS Adjustments, ₹m Q4FY25 Q1FY26 Ind AS Ind AS Ind AS Ind AS Reported Reported Impact Adjusted Impact Adjusted Revenue 15,096.1 - 15,096.1 15,426.3 - 15,426.3 Gross Margin 4,009.7 - 4,009.7 4,029.0 - 4,029.0 Gross
Slide 19: Operating EBITDA Deep Dive
Results Update Operating EBITDA Deep Dive Operating EBITDA Bridge: From 12+ Months Stores to Consolidated, ₹m 727 41 728 -3 -16 690 -21 Operating 12+ Months < 12 Months Pre-Operative Pharmacy Diagnostics Others Consolidated EBITDA Stores Stores* * Includes all Franchisee stores Q1FY26 17
Slide 20: Balance Sheet
Results Update Balance Sheet Key Balance Sheet items, ₹m Jun-24 Mar-25 Jun-25 Assets PPE and CWIP 3,122.9 3,038.5 3,019.9 Inventories 14,480.6 13,451.0 12,729.7 Cash 1,592.5 4,422.6 5,549.3 Liabilities Trade payables 3,376.0 2,989.6 2,797.7 1. Cash includes cash, bank balances and bank deposits Q1FY
Slide 21: Capital Productivity
Results Update Capital Productivity Working Capital Cycle, days ROCE2: Operating EBIT/ Avg. Capital Employed NWC (days) 69 61 61 63 59 19.3% 18.7% Year 1 Stores 48 17.0% 97 days inventory 43 15.4% 41 40 39 (on Year 1 stores revenue) 40 38 36 37 36 Stores Older Than 12 months 6.9% 21 39 days inventor
Slide 22: Cash Management
Results Update Cash Management Cash Management, Q1FY26, ₹m 4,000 Operating Cash Flow 3,500 ₹ 1,872m 3,000 Free Cash Flow ₹ 1,072m 2,500 2,000 579 -104 1,500 1,397 -183 110 1,182 1,000 -618 500 0 PBT+ Decrease Taxes Capex Payment Interest Increase D&A+ Int. in Working of lease received in cash of Lea
Slide 23: Appendix
Appendix A. The Board of Directors and Key Managerial Personnel B. Glossary 21
Slide 24: The Board of Directors and Management Team
A. The Board of Directors and Management Team Appendix Mr. Gangadi Madhukar Reddy Dr. Cherukupalli Bhaskar Reddy Mr. Murali Sivaraman Ms. Aparna Surabhi Mr. Madhavan Ganesan Mr. Thyagarajan Muralidharan Chairman, Managing Director Whole Time Director Non-Executive Non-Executive Non-Executive Non-Exe
Slide 25: Glossary
B. Glossary Appendix Term Description Metro: Bengaluru, Chennai (and Avadi), Hyderabad, Kolkata (and Howrah), Mumbai (and Thane) City Categorization Tier One: Ahmednagar, Baramati, Kharagpur, Nagpur, Nashik, Panruti, Pune, Ranaghat, Vijayawada, Visakhapatnam (internal) Tier Two: Hundred and Twenty-N
Slide 26: MedPlus Health Services Limited contact details
MEDPLUS HEALTH SERVICES LIMITED Manoj Kumar Srivastava Company Secretary & Compliance Officer manoj.srivastava@medplusindia.com cs@medplusindia.com Website: www.medplusindia.com INVESTOR RELATIONS Tanushree Chaurasia ir@medplusindia.com MEDIA AND PRESS ENQUIRIES marketing@medplusindia.com Reg. Offic
MedPlus Health Services — Q1 FY2026 Earnings Presentation on 6ix